SALMONELLA-TYPHI VACCINE STRAIN CVD-908 EXPRESSING THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM-FALCIPARUM - STRAIN CONSTRUCTION AND SAFETY AND IMMUNOGENICITY IN HUMANS

被引:99
作者
GONZALEZ, C
HONE, D
NORIEGA, FR
TACKET, CO
DAVIS, JR
LOSONSKY, G
NATARO, JP
HOFFMAN, S
MALIK, A
NARDIN, E
SZTEIN, MB
HEPPNER, DG
FOUTS, TR
ISIBASI, A
LEVINE, MM
机构
[1] UNIV MARYLAND, SCH MED, CTR VACCINE DEV, BALTIMORE, MD 21201 USA
[2] NATL NAVAL MED CTR, BETHESDA, MD 20814 USA
[3] INST MEXICANO SEGURO SOCIAL, UNIDAD INVEST MED & IMMUNOQUIM, MEXICO CITY, DF, MEXICO
[4] NYU, SCH MED, DEPT MED & MOLEC PARASITOL, NEW YORK, NY USA
关键词
D O I
10.1093/infdis/169.4.927
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
rcsp, encoding amino acids 21-398 of Plasmodium falciparum circumsporozoite protein (CSP), under control of P-tac was integrated into the chromosomal Delta aroC locus of attenuated Delta aroC, Delta aroD Salmonella typhi CVD 908. By immunoblot and ELISA, rCSP expression was greater from a multicopy plasmid than from the single chromosomal gene. CVD 908 Omega(Delta aroC1019::P-tac-rcsp) was well tolerated by 10 volunteers who were fed two doses of 5 x 10(7) organisms 8 days apart. Seven subjects excreted the vaccine strain for 1-3 days. All subjects developed serologic responses to O and H antigens of the live vector, whereas 3 vaccinees responded to the foreign antigen: 1 developed an 80-fold rise in serum anti-sporozoite antibody, another had a 4-fold rise in antibody to a recombinant portion of CSP (residues 309-345), while a third vaccinee developed CSP-specific CD8(+) cytotoxic T lymphocyte activity. This is the first report of attenuated S. typhi eliciting a human serologic or a cytotoxic T lymphocyte response to a foreign protein. Improved foreign gene expression should enhance immunogenicity.
引用
收藏
页码:927 / 931
页数:5
相关论文
共 15 条
[1]  
BALLOU WR, 1987, LANCET, V1, P1277
[2]   CHARACTERIZATION OF NATURALLY ACQUIRED ANTIBODIES TO THE NONREPETITIVE FLANKING REGIONS OF THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM-FALCIPARUM [J].
BROWN, AE ;
WEBSTER, HK ;
GORDON, DM ;
PERMPANICH, B ;
GROSS, M .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1992, 47 (04) :440-445
[3]  
CALLE JMC, 1992, J IMMUNOL, V149, P2695
[4]   PLASMODIUM-FALCIPARUM - INVITRO CHARACTERIZATION AND HUMAN INFECTIVITY OF A CLONED LINE [J].
DAVIS, JR ;
CORTESE, JF ;
HERRINGTON, DA ;
MURPHY, JR ;
CLYDE, DF ;
THOMAS, AW ;
BAQAR, S ;
COCHRAN, MA ;
THANASSI, J ;
LEVINE, MM .
EXPERIMENTAL PARASITOLOGY, 1992, 74 (02) :159-168
[5]  
DELGIUDICE G, 1988, IMMUNOLOGY, V63, P187
[6]   HUMORAL IMMUNE-RESPONSES IN VOLUNTEERS IMMUNIZED WITH IRRADIATED PLASMODIUM-FALCIPARUM SPOROZOITES [J].
EGAN, JE ;
HOFFMAN, SL ;
HAYNES, JD ;
SADOFF, JC ;
SCHNEIDER, I ;
GRAU, GE ;
HOLLINGDALE, MR ;
BALLOU, WR ;
GORDON, DM .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 49 (02) :166-173
[7]  
FOUTS TR, 1993, VACCINES93 : MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P95
[8]   LIPOSOMAL MALARIA VACCINE IN HUMANS - A SAFE AND POTENT ADJUVANT STRATEGY [J].
FRIES, LF ;
GORDON, DM ;
RICHARDS, RL ;
EGAN, JE ;
HOLLINGDALE, MR ;
GROSS, M ;
SILVERMAN, C ;
ALVING, CR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (01) :358-362
[9]   SUCCESSFUL IMMUNIZATION OF HUMANS WITH IRRADIATED MALARIA SPOROZOITES - HUMORAL AND CELLULAR-RESPONSES OF THE PROTECTED INDIVIDUALS [J].
HERRINGTON, D ;
DAVIS, J ;
NARDIN, E ;
BEIER, M ;
CORTESE, J ;
EDDY, H ;
LOSONSKY, G ;
HOLLINGDALE, M ;
SZTEIN, M ;
LEVINE, M ;
NUSSENZWEIG, RS ;
CLYDE, D ;
EDELMAN, R .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1991, 45 (05) :539-547
[10]   SAFETY AND IMMUNOGENICITY IN MAN OF A SYNTHETIC PEPTIDE MALARIA VACCINE AGAINST PLASMODIUM-FALCIPARUM SPOROZOITES [J].
HERRINGTON, DA ;
CLYDE, DF ;
LOSONSKY, G ;
CORTESIA, M ;
MURPHY, JR ;
DAVIS, J ;
BAQAR, S ;
FELIX, AM ;
HEIMER, EP ;
GILLESSEN, D ;
NARDIN, E ;
NUSSENZWEIG, RS ;
NUSSENZWEIG, V ;
HOLLINGDALE, MR ;
LEVINE, MM .
NATURE, 1987, 328 (6127) :257-259